Document is current
Any future updates will be listed below
-
Authors
Giugliano, Dario https://orcid.org/0000-0002-9377-873X
Longo, Miriam
Scappaticcio, Lorenzo
Caruso, Paola https://orcid.org/0000-0002-4756-2022
Gicchino, Maurizio
Petrizzo, Michela
Bellastella, Giuseppe https://orcid.org/0000-0002-4748-321X
Maiorino, Maria Ida https://orcid.org/0000-0003-4659-7546
Esposito, Katherine https://orcid.org/0000-0002-3652-5154
-
Funding
Funding for this research was provided by:
Associazione Salute con Stile (1.2022)
- License Information
-
More Information
Article History
Received: 30 August 2023
Accepted: 18 September 2023
First Online: 3 October 2023
Compliance with ethical standards
:
: D.G. received honoraria for speaking at meetings from Sanofi, Eli Lilly, and Company, AstraZeneca, and Novo Nordisk. M.I.M. received honoraria for speaking at meetings from Novo Nordisk, Sanof, and Eli-Lilly. K.E. received honoraria for speaking at meetings from Sanofi Aventis, Eli Lilly, and Novo Nordisk. No other potential conflicts of interest relevant to this article were reported.
: Informed consent was obtained from all individual participants included in the study.
: This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the Medical Ethics Committee of University of Campania Luigi Vanvitelli (prot 731 26.11.2019) and registered at ClinicalTrial.gov NCT04196231.
